|
Volumn 307, Issue 23, 2012, Pages 2475-2476
|
IOM urges FDA to be more aggressive in monitoring safety of approved drugs
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG APPROVAL;
DRUG INDICATION;
DRUG INFORMATION;
DRUG LABELING;
DRUG MONITORING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
|
EID: 84862501738
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2012.5993 Document Type: Short Survey |
Times cited : (1)
|
References (0)
|